Lingzhi Wang

8.6k total citations · 6 hit papers
148 papers, 6.4k citations indexed

About

Lingzhi Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lingzhi Wang has authored 148 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 35 papers in Oncology and 35 papers in Cancer Research. Recurrent topics in Lingzhi Wang's work include MicroRNA in disease regulation (13 papers), Extracellular vesicles in disease (12 papers) and Cancer therapeutics and mechanisms (10 papers). Lingzhi Wang is often cited by papers focused on MicroRNA in disease regulation (13 papers), Extracellular vesicles in disease (12 papers) and Cancer therapeutics and mechanisms (10 papers). Lingzhi Wang collaborates with scholars based in Singapore, China and United States. Lingzhi Wang's co-authors include Gautam Sethi, Boon Cher Goh, Boon-Cher Goh, Nicholas Syn, Zhaowu Ma, Alan Prem Kumar, Xiaoqiang Xiang, Andrea Li‐Ann Wong, Jean Paul Thiery and Muthu K. Shanmugam and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Lingzhi Wang

142 papers receiving 6.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-Mediated Metastasis: From Epithelial–Mesenchymal Transition to Escape from Immunosurveillance

2016 402 citations Nicholas Syn, Lingzhi Wang et al. profile →
Resveratrol for cancer therapy: Challenges and future perspectives

2021 334 citations Boxu Ren, Zhaowu Ma et al. Cancer Letters profile →
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

2024 220 citations Qiang Lü, Dongquan Kou et al. Journal of Hematology & Oncology profile →
Autophagy in cancer development, immune evasion, and drug resistance

2024 60 citations Yu Tian, Milad Ashrafizadeh et al. profile →
Autophagy in aging-related diseases and cancer: Principles, regulatory mechanisms and therapeutic potential

2024 37 citations Wenhui Zheng, Yu Tian et al. Ageing Research Reviews profile →
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy

2025 22 citations Andrea Li‐Ann Wong, Lingzhi Wang et al. profile →

Peers

Countries citing papers authored by Lingzhi Wang

Since Specialization

Citations

This map shows the geographic impact of Lingzhi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingzhi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingzhi Wang more than expected).

Fields of papers citing papers by Lingzhi Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingzhi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingzhi Wang. The network helps show where Lingzhi Wang may publish in the future.

Co-authorship network of co-authors of Lingzhi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lingzhi Wang. A scholar is included among the top collaborators of Lingzhi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingzhi Wang. Lingzhi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Esketamine on Postoperative Delirium and Postoperative Cognitive Function in Elderly Gastrointestinal Tumor Patients with Preoperative Anxiety 2025 ·Drug Design Development and Therapy ·(unknown), (unknown), (unknown), Rui Shi, (unknown), (unknown), Xiaoshu Chen, Xiaoying Lan, (unknown), Lingzhi Wang	0
2	Dried tangerine peel polysaccharide accelerates wound healing by recruiting anti-inflammatory macrophages 2024 ·International Immunopharmacology ·(unknown), Lingzhi Wang, Wenxi Li, Yinggang Li, (unknown), Jucai Xu, Wu Li, (unknown), (unknown), Yanxian Feng, Suqin Guo, Hui Liu	0
3	Extracellular vesicle-derived biomarkers in prostate cancer care: Opportunities and challenges 2024 ·Cancer Letters ·Xiaoxiao Wang, (unknown), (unknown), Yufei Wang, (unknown), Jiahui Yu, Zhaowu Ma, Paul C. Ho, Gautam Sethi, Xiaoguang Chen, Lingzhi Wang, Boon Cher Goh	3
4	Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy breakdown → 2024 ·Journal of Hematology & Oncology ·Qiang Lü, Dongquan Kou, Shenghan Lou, Milad Ashrafizadeh, Amir Reza Aref, Israel Cañadas, Yu Tian, Xiaojia Niu, Yuzhuo Wang, Pedram Torabian, Lingzhi Wang, Gautam Sethi, Vinay Tergaonkar, Franklin R. Tay, Zhennan Yuan, Peng Han	220
5	Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges 2024 ·Cancers ·(unknown), (unknown), (unknown), Xiaoguang Chen, Lian Liu, Boxu Ren, Lingzhi Wang, Boon-Cher Goh	19
6	Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies 2024 ·Antioxidants and Redox Signaling ·Jiaqi Li, (unknown), Jie Qing Eu, (unknown), Boon Cher Goh, Lingzhi Wang, Andrea Li‐Ann Wong	12
7	Autophagy in aging-related diseases and cancer: Principles, regulatory mechanisms and therapeutic potential breakdown → 2024 ·Ageing Research Reviews ·(unknown), Wenhui Zheng, (unknown), Yu Tian, Min Tang, Xiaoqiang Feng, Milad Ashrafizadeh, Yuzhuo Wang, Xiaojia Niu, Murtaza M. Tambuwala, Lingzhi Wang, Vinay Tergaonkar, Gautam Sethi, Daniel J. Klionsky, Li Huang, Ming Gu	37
8	Effect of Ultrasound‐Guided External Oblique Intercostal Block on Postoperative Recovery After Subxiphoid Video‐Assisted Thoracoscopic Thymectomy 2024 ·Journal of Ultrasound in Medicine ·Zhiang Li, (unknown), (unknown), Lingzhi Wang, Xuwei Zhang, (unknown)	1
9	Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy 2023 ·Cancer Research ·(unknown), Ling‐Wen Ding, (unknown), Henry Yang, Jonathan W. Said, (unknown), Vikas Madan, Pushkar Dakle, Jin-Fen Xiao, (unknown), Ying Li, Liang Xu, Xiaoqiang Xiang, Lingzhi Wang, Boon Cher Goh, De‐Chen Lin, Wee Joo Chng, Soo‐Yong Tan, Sudhakar Jha, H. Phillip Koeffler	12
10	Effects of anterior approach to quadratus lumborum block on postoperative cognitive function following hip surgery in older people: a randomized controlled clinical trial 2023 ·BMC Geriatrics ·Manhua Zhu, (unknown), (unknown), Lingzhi Wang, Xiaoyan Zhang	2
11	Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy 2022 ·Journal of Extracellular Vesicles ·Boya Peng, (unknown), Migara Kavishka Jayasinghe, Chang Gao, Thach Tuan Pham, Luyen Tien Vu, Eric Yeo, Gracemary Yap, Lingzhi Wang, Boon Cher Goh, Wai Leong Tam, Dahai Luo, Minh T. N. Le	67
12	Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers 2021 ·Cell Death Discovery ·Ser Yue Loo, Nicholas Syn, (unknown), (unknown), Amudha Deivasigamani, Tuan Zea Tan, Aye Aye Thike, Shireen Vali, Shweta Kapoor, Xiaoyuan Wang, Jiong‐Wei Wang, Puay Hoon Tan, George W. Yip, Gautam Sethi, Ruby Yun‐Ju Huang, Kam M. Hui, Lingzhi Wang, Boon Cher Goh, Alan Prem Kumar	12
13	Aged Brains Express Less Melanocortin Receptors, Which Correlates with Age-Related Decline of Cognitive Functions 2021 ·Molecules ·Yang Zhou, Monica K. Chawla, (unknown), Lingzhi Wang, (unknown), Victor J. Hruby, Carol A. Barnes, Minying Cai	13
14	PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases 2020 ·Clinical Cancer Research ·Guowei Kim, (unknown), Raghav Sundar, Bettina Lieske, Cheng Ean Chee, Jingshan Ho, Asim Shabbir, Maria V. Babak, Wee Han Ang, Boon Cher Goh, Wei Peng Yong, Lingzhi Wang, Jimmy Bok Yan So	37
15	Safety, pharmacokinetics and tissue penetration of PIPAC paclitaxel in a swine model 2020 ·European Journal of Surgical Oncology ·(unknown), Guowei Kim, Christopher J. Charles, (unknown), (unknown), Asim Shabbir, (unknown), (unknown), Raghav Sundar, Boon Cher Goh, Glenn Kunnath Bonney, (unknown), (unknown), Jimmy Bok Yan So, Lingzhi Wang, Wei Peng Yong	12
16	MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma 2019 ·Blood ·Boheng Li, Junli Yan, (unknown), (unknown), Tae‐Hoon Chung, Nurulhuda Mustafa, (unknown), Lingzhi Wang, Pieter J.A. Eichhorn, Boon-Cher Goh, Siok‐Bian Ng, Dennis Kappei, Wee Joo Chng	29
17	Role of tumor-derived exosomes in cancer metastasis 2018 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·(unknown), Nicholas Syn, Gautam Sethi, Boon Cher Goh, Lingzhi Wang	90
18	Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis 2018 ·PubMed ·Guowei Kim, (unknown), (unknown), (unknown), (unknown), Jingshan Ho, Yvonne Ang, Natalie Y.L. Ngoi, Cheng Ean Chee, Bettina Lieske, Asim Shabbir, Lingzhi Wang, Jimmy Bok Yan So, Wei Peng Yong	20
19	Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditions 2017 ·Scientific Reports ·F. Yu, Yanan Lu, Lin Tao, Yan‐Yi Jiang, De‐Chen Lin, Lingzhi Wang, Fredrik Petersson, Hironori Yoshiyama, Phillip H. Koeffler, Boon-Cher Goh, Kwok Seng Loh	18
20	Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography–tandem mass spectrometry 2011 ·Journal of Chromatography A ·Lingzhi Wang, (unknown), (unknown), (unknown), (unknown), Andrea Li‐Ann Wong, Sui Yung Chan, Boon-Cher Goh, Paul C. Ho	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact